Biocompatible medical device coatings

• US 20040148016A1
• Filed: 11/06/2003
• Published: 07/29/2004
• Est. Priority Date: 11/07/2002
• Status: Abandoned Application

• Current Assignee: Carbon Medical Technologies, Inc.
• Original Assignee: Carbon Medical Technologies, Inc.
• Inventors: Klein, Dean A., Brazil, James D.
• Application Number:
  US10/702,846
• Publication Number:
  US 20040148016A1
• Time in Patent Office: Days
• US Class Current: 623/1.42
• CPC Class Codes: A61L 2420/04 Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/14 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: C08L 61/04 Condensation polymers of aldehydes or ketones with phenols only
• CPC Class Codes: C08L 61/06 of aldehydes with phenols

Abstract

The present invention provides a coated medical device including a biocompatible coating. The biocompatible coating includes a phenolic resin and at least one particulate material dispersed within the resin that affects a functional property of the coating. For example, the particulate material may affect surface properties of the coating, such as lubricity, sorption and surface area. The biocompatible coating of the present invention is biocompatible and adheres well to a variety of medical devices. The biocompatible coating may be enhanced by the incorporation of lubricants or bioactive agents into or onto the coating.

Claims

1. A coated medical device comprising:

an implantable substrate; and

a biocompatible coating fixed to a surface of the substrate, the coating including a phenolic resin and at least one particulate material dispersed within the phenolic resin that affects a functional property of the coating.

2. The medical device of claim 1 wherein the phenolic resin comprises a resole resin, a polyvinyl phenol resin or a novolak resin.

3. The medical device of claim 1 wherein the particulate material comprises a polymeric material, a metal, a ceramic material or a combination thereof.

4. The medical device of claim 1 wherein the particulate material comprises a transition metal.

5. The medical device of claim 1 wherein the particulate material comprises molybdenum.

6. The medical device of claim 1 wherein the particulate material comprises molybdenum disulfide.

7. The medical device of claim 1 wherein the particulate material comprises a fluorocarbon.

8. The medical device of claim 1 wherein the particulate material comprises PTFE.

9. The medical device of claim 1 wherein the particulate material comprises zirconium oxide.

10. The medical device of claim 1 wherein the particles have a major dimension of less than 300 mil.

11. The medical device of claim 1 wherein the particles have a major dimension of less than about 3 mil.

12. The medical device of claim 1 comprising at least two particulate materials dispersed within the phenolic resin.

13. The medical device of claim 1 further comprising a biologically active agent.

14. The medical device of claim 13 wherein the biologically active agent is dispersed within the phenolic resin.

15. The medical device of claim 13 wherein the biologically active agent is applied onto an exposed surface of the phenolic resin.

16. The medical device of claim 13 wherein the biologically active agent comprises an anti-thrombin, anti-microbial, anti-restenosis or anti-inflammatory agent.

17. The medical device of claim 1 further comprising a lubricant applied onto an exposed surface of the phenolic resin.

18. The medical device of claim 17 wherein the lubricant comprises β

-glucan.

19. The medical device of claim 1 comprising a plurality of coating layers.

20. The medical device of claim 1 comprising a first coating layer applied to the medical device, and a biologically active agent, lubricant, or both applied to an exposed surface of the first coating layer.

21. The medical device of claim 1 comprising a first coating layer applied to the surface of the medical device, a second coating layer applied to the first coating layer, and a biologically active agent disposed between the first and second layers.

22. The medical device of claim 1 wherein a surface of the medical device is coated with a biologically active agent prior to the application of the coating.

23. The medical device of claim 1 wherein the coating has a thickness of less than about 300 mil.

24. The medical device of claim 1 wherein the coating has a thickness of between about 1 mil and 300 mil.

25. The medical device of claim 1 wherein the coating has a thickness of between about 2 mil and 200 mil.

26. A coated stent comprising:

a stent body; and

a biocompatible coating fixed to the stent body, the coating including a phenolic resin and at least one particulate material dispersed within the phenolic resin that affects a functional property of the coating.

27. The coated stent of claim 26 wherein the stent body comprises a metal or polymeric material.

28. The coated stent of claim 26 wherein the stent body is self-expandable or balloon expandable.

29. A method of treating stenosis of a lumen comprising:

inserting into the lumen a coated stent in a contracted position, the coated stent comprising a stent body and a biocompatible coating fixed to the stent body, the coating including a phenolic resin and at least one particulate material dispersed within the phenolic resin that affects a functional property of the coating; and

expanding the stent into an expanded position within the lumen.

30. The method of claim 29 wherein the expanding step comprises self-expanding or balloon-expanding the stent from the contracted to the expanded position.